1,031 filings
Page 5 of 52
8-K
CLRB
Cellectar Biosciences Inc
13 Sep 22
Other Events
8:45am
S-8
CLRB
Cellectar Biosciences Inc
5 Aug 22
Registration of securities for employees
4:32pm
10-Q
2022 Q2
CLRB
Cellectar Biosciences Inc
Quarterly report
5 Aug 22
8:46am
8-K
CLRB
Cellectar Biosciences Inc
5 Aug 22
Cellectar Reports Financial Results for Second Quarter 2022
8:40am
4
Swirsky Douglas J
1 Aug 22
Cellectar Biosciences / Douglas J Swirsky ownership change
6:01pm
4
CLRB
Cellectar Biosciences Inc
1 Aug 22
Cellectar Biosciences / JOHN NEIS ownership change
6:01pm
4
Loren Stefan
1 Aug 22
Cellectar Biosciences / Stefan Loren ownership change
6:01pm
4
Driscoll Frederick W
1 Aug 22
Cellectar Biosciences / FREDERICK W DRISCOLL ownership change
6:00pm
4
Asher Chanan-Khan
1 Aug 22
Cellectar Biosciences / Asher Chanan-Khan ownership change
6:00pm
8-K
CLRB
Cellectar Biosciences Inc
21 Jul 22
Cellectar Announces Stock Consolidation
4:30pm
8-K
CLRB
Cellectar Biosciences Inc
27 Jun 22
Departure of Directors or Certain Officers
4:30pm
DEFR14A
CLRB
Cellectar Biosciences Inc
7 Jun 22
Revised proxy
5:09pm
DEFA14A
CLRB
Cellectar Biosciences Inc
6 Jun 22
Additional proxy soliciting materials
7:20pm
8-K
CLRB
Cellectar Biosciences Inc
6 Jun 22
Other Events
7:18pm
10-Q
2022 Q1
CLRB
Cellectar Biosciences Inc
Quarterly report
10 May 22
8:45am
8-K
CLRB
Cellectar Biosciences Inc
10 May 22
Cellectar Reports Financial Results for First Quarter 2022 and Provides a Corporate Update
8:41am
8-K
CLRB
Cellectar Biosciences Inc
6 May 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
DEF 14A
CLRB
Cellectar Biosciences Inc
Definitive proxy
29 Apr 22
4:16pm
8-K
CLRB
Cellectar Biosciences Inc
26 Apr 22
Cellectar Biosciences Announces Positive DMC Review of Pivotal Trial of Iopofosine in Waldenstrom’s Macroglobulinemia
4:47pm
PRE 14A
CLRB
Cellectar Biosciences Inc
Preliminary proxy
19 Apr 22
5:00pm